Madeleine Fosslie

Madeleine Fosslie

Auto-generated profile, based on publicly available information

Madeleine Fosslie

Department of Microbiology, Oslo University Hospital, Oslo, Norway

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2023 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
YLYanjiao Li
Yanjiao Li
YWYunhao Wang
Yunhao Wang
MVMaria Vera-Rodriguez
Maria Vera-Rodriguez
LLLeif Christopher Lindeman
Leif Christopher Lindeman
LSLinda Ellevog Skuggen
Linda Ellevog Skuggen
JDJohn Arne Dahl
John Arne Dahl
Current N6-methyladenosine (m6A) mapping methods need large amounts of RNA or are limited to cultured cells. Through optimized sample recovery and signal-to-noise ratio, we developed picogram-scale m6A RNA immunoprecipitation and sequencing (picoMeRIP–seq) for studying m6A in vivo in single cells and scarce cell types using standard laboratory equipment. We benchmark m6A mapping on titrations of poly(A) RNA and embryonic stem cells and in single zebrafish zygotes, mouse oocytes and embryos.

11 September 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
RZRosalie T. Zwiggelaar
Rosalie T. Zwiggelaar
HLHåvard T Lindholm
Håvard T Lindholm
MFMadeleine Fosslie
Madeleine Fosslie
MPMarianne Terndrup Pedersen
Marianne Terndrup Pedersen
YOYuki Ohta
Yuki Ohta
MOMenno J. Oudhoff
Menno J. Oudhoff
Intestinal epithelial homeostasis is maintained by adult intestinal stem cells, which, alongside Paneth cells, appear after birth in the neonatal period. We aimed to identify regulators of neonatal intestinal epithelial development by testing a small library of epigenetic modifier inhibitors in Paneth cell–skewed organoid cultures. We found that lysine-specific demethylase 1A (Kdm1a/Lsd1) is absolutely required for Paneth cell differentiation. Lsd1-deficient crypts, devoid of Paneth cells, are still able to form organoids without a requirement of exogenous or endogenous Wnt. Mechanistically, we find that LSD1 enzymatically represses genes that are normally expressed only in fetal and neonatal epithelium. This gene profile is similar to what is seen in repairing epithelium, and we find that Lsd1-deficient epithelium has superior regenerative capacities after irradiation injury. In summary, we found an important regulator of neonatal intestinal development and identified a druggable target to reprogram intestinal epithelium toward a reparative state.

31 March 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
NPNaveen Parmar
Naveen Parmar
KBKyle Burrows
Kyle Burrows
PVPia M. Vornewald
Pia M. Vornewald
HLHåvard T Lindholm
Håvard T Lindholm
RZRosalie T. Zwiggelaar
Rosalie T. Zwiggelaar
MOMenno J. Oudhoff
Menno J. Oudhoff
Infectious and inflammatory diseases in the intestine remain a serious threat for patients world-wide. Reprogramming of the intestinal epithelium towards a protective effector state is important to manage inflammation and immunity and can be therapeutically targeted. The role of epigenetic regulatory enzymes within these processes is not yet defined. Here, we use a mouse model that has an intestinal-epithelial specific deletion of the histone demethylase Lsd1 (cKO mice), which maintains the epithelium in a fixed reparative state. Challenge of cKO mice with bacteria-induced colitis or a helminth infection model both resulted in increased pathogenesis. Mechanistically, we discovered that LSD1 is important for goblet cell maturation and goblet-cell effector molecules such as RELMß. We propose that this may be in part mediated by directly controlling genes that facilitate cytoskeletal organization, which is important in goblet cell biology. This study therefore identifies intestinal-epithelial epigenetic regulation by LSD1 as a critical element in host protection from infection.

3 September 2019 in WIREs Mechanisms of Disease
Verified
Journal Article
Closed access
PDF file
MFMadeleine Fosslie
Madeleine Fosslie
AMAdeel Manaf
Adeel Manaf
MLMads Lerdrup
Mads Lerdrup
KHKlaus Hansen
Klaus Hansen
GGGregor D. Gilfillan
Gregor D. Gilfillan
JDJohn Arne Dahl
John Arne Dahl

4 June 2025 in The EMBO Journal
Verified
Journal Article
Open access
YLYanjiao Li
Yanjiao Li
YWYunhao Wang
Yunhao Wang
ACAylin Cengiz
Aylin Cengiz
KJKang-Xuan Jin
Kang-Xuan Jin
BCBlanca Corral Castroviejo
Blanca Corral Castroviejo
AKArne Klungland
Arne Klungland
RNA N 6 -methyladenosine (m 6 A, m6A) modification is a critical regulator for a range of physiological processes. However, the dynamic m 6 A profiles within human preimplantation embryos remain uncharacterized. Here, we present the first RNA m 6 A landscape of single human oocytes and early embryos. Comparative analyses with mouse data reveal an intriguing divergence during the window of zygotic genome activation. m 6 A-modified genes are involved in regulation of gene transcription, while unmodified genes are mainly associated with basic metabolic processes. Maternal decay mRNAs exhibit a propensity for m 6 A modifications, and these genes are targeted by miRNAs. m 6 A modified genes that are constantly expressed across all stages demonstrate higher translation efficiency. Moreover, we observe frequent m 6 A enrichment on stage-specifically expressed retrotransposons, particularly within young subfamilies. m 6 A inhibitor leads to m 6 A erasure on massive retrotransposons. In summary, this study provides a resource to broaden our understanding about the regulatory roles of m 6 A during early human embryo development.

27 October 2025 in Development
Verified
Journal Article
Open access
TSTrine Skuland
Trine Skuland
MFMadeleine Fosslie
Madeleine Fosslie
SKSherif Khodeer
Sherif Khodeer
EAEndalkachew Ashenafi Alemu
Endalkachew Ashenafi Alemu
JJJens Vilstrup Johansen
Jens Vilstrup Johansen
GGGareth D. Greggains
Gareth D. Greggains
Epigenetic reprogramming and embryonic genome activation (EGA) are crucial events during early development. Establishment of distinctive broad histone H3 lysine 4 trimethylation (H3K4me3) domains in the oocyte is necessary for genome silencing, and their removal in the 2-cell embryo is crucial for EGA and development in mice. However, the stage-specific requirement for broad H3K4me3 domains is unclear. Here, we show that inducing broad H3K4me3 removal in mouse oocytes can relieve genome silencing, impair oocyte maturation timing, and may cause transcriptional reactivation in resulting parthenogenetic 1-cell embryos. We further demonstrate that broad H3K4me3 demethylation precedes EGA but, surprisingly, premature depletion in zygotes or early 2-cell embryos does not alter the transcriptional program. Our findings suggest that broad H3K4me3 domains are required for oocyte genome silencing, timely maturation and post-fertilisation silencing, but onward pre-EGA transcriptional repression is not dependent on the original mark. This work contributes to the understanding of events and mechanisms involved in genome silencing and activation in early development, providing insight into potential modes of failure that may contribute to infertility.